Venous thromboembolism in patients with breast, ovarian, and uterine cancer. A comparative analysis from the Registro Informatizado Enfermedad TromboEmbólica registry
VTE outcomes vary significantly by cancer type. Patients with uterine cancer face an elevated bleeding risk, potentially impacting anticoagulant continuity and contributing to VTE recurrence. These findings support the need for cancer-specific risk assessment and individualized anticoagulation strategies adapted to the specific cancer type.
Authors
- Olga Gavín‐Sebastián (ORCID: https://orcid.org/0000-0002-5913-9125)
- Carmen Díaz‐Pedroche (ORCID: https://orcid.org/0000-0001-9809-0363)
- S. Otálora
- A. Bura-Rivière (ORCID: https://orcid.org/0000-0001-7469-2407)
- Benjamin Brenner (ORCID: https://orcid.org/0000-0003-3139-085X)
- Luis Blasco (ORCID: https://orcid.org/0000-0001-7484-2452)
- José María Pedrajas (ORCID: https://orcid.org/0000-0002-3597-1398)
- Mafalda Santos (ORCID: https://orcid.org/0000-0001-8432-1968)
- Manuel Monréal (ORCID: https://orcid.org/0000-0002-0494-0767)
- Pablo Demelo-Rodríguez
Institutions
- Universitat de Miguel Hernández d'Elx (ES)
- Rambam Health Care Campus (IL)
- Hospital General Universitario Gregorio Marañón (ES)
- Hospital Clínico San Carlos (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Hospital Universitario 12 De Octubre (ES)
- Hôpital Rangueil (FR)
- Hospital Clínico Universitario Lozano Blesa (ES)
- Hospital General Universitario de Alicante Doctor Balmis (ES)
- Santa Lucía University General Hospital (ES)
- Hospital Universitario Virgen de la Arrixaca (ES)
- Universidad Católica de Murcia (ES)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1016/j.rpth.2025.103301
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00